跳转至内容
Merck
CN

P-055

普萘洛尔 盐酸盐 溶液

1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C16H21NO2·HCl
化学文摘社编号:
分子量:
295.80
NACRES:
NA.24
UNSPSC Code:
41116107
EC Number:
200-659-6
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

certified reference material

Quality Level

form

liquid

feature

Snap-N-Spike®/Snap-N-Shoot®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

concentration

1.0 mg/mL in methanol (as free base)

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

clinical testing

format

single component solution

storage temp.

−20°C

SMILES string

Cl.CC(C)NCC(O)COc1cccc2ccccc12

InChI

1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H

InChI key

ZMRUPTIKESYGQW-UHFFFAOYSA-N

Gene Information

General description

一种经认证的参比溶液,适用于临床和诊断测试、尿液药物测试、法医分析或临床毒理学的LC/MS或GC/MS测试方法的校准器和控制的起始材料。普萘洛尔是一种交感神经非选择性受体阻滞剂,用于治疗高血压、焦虑和恐慌等多种疾病。该药物以Inderal®、Avlocardyl、Deralin和Dociton等许多商品名出售。

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Inderal is a registered trademark of Cranford Pharmaceuticals, LLC
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.


signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes

存储类别

3 - Flammable liquids

wgk

WGK 1

flash_point_f

49.5 °F - closed cup

flash_point_c

9.7 °C - closed cup

法规信息

危险化学品

此项目有



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

This article highlights the impact that sample matrix effects can have on LC/MS response and discusses two novel approaches to reduce it.

Comparative analysis of Supel™ BioSPME 96-Pin device with a rapid equilibrium dialysis technique for accuracy of measured values, sample cleanliness, and workflow time in drug protein binding.

Learn about Supel™ BioSPME C18 high-throughput devices to determine plasma protein binding and decrease the sample preparation time to less than an hour.


[Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].
Carl Johan Rosenkvist et al.
Lakartidningen, 110(19-20), 942-945 (2013-06-12)
Practice gaps. Propranolol to treat hemangiomas of infancy: safety and side effect recognition.
Jonathan A Dyer
JAMA dermatology, 149(4), 485-486 (2013-05-30)
Amy C Arnold et al.
Neurology, 80(21), 1927-1933 (2013-04-26)
To determine the effect of low-dose propranolol on maximal exercise capacity in patients with postural tachycardia syndrome (POTS). We compared the effect of placebo vs a single low dose of propranolol (20 mg) on peak oxygen consumption (VO2max), an established



全球贸易项目编号

货号GTIN
P-055-1ML04061834253761